Companion Animal Pharmaceuticals Global Market Report 2024

Global Companion Animal Pharmaceuticals Market Report 2024

Companion Animal Pharmaceuticals Global Market Report 2024 – By Animal Type (Dogs, Cats, Horses, Other Companion Animals ), By Indication (Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications ), By Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies ) – Market Size, Trends, And Global Forecast 2024-2033

Name: Companion Animal Pharmaceuticals Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Companion Animal Pharmaceuticals Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 200 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Companion Animal Pharmaceuticals Market Definition

Companion animal pharmaceuticals refer to the pharmaceutical medication process in which animal pharmacists insist on medications, fill prescriptions, and manage drug therapies for animals. It is used in the diagnosis, mitigation, and treatment of different animal diseases.

The main types of companion animal pharmaceuticals are dogs, cats, horses, and other companion animals. Dogs refer to a highly variable carnivorous domesticated mammal of the genus closely related to the common wolf. The indications are infectious diseases, dermatologic diseases, pain, orthopaedic diseases, behavioral diseases, and other indications, which are sold through multiple distribution channels involved veterinary hospitals, veterinary clinics, and retail pharmacies.

Companion Animal Pharmaceuticals Market Segmentation

The companion animal pharmaceuticals market covered in this report is segmented –

1) By Animal Type: Dogs, Cats, Horses, Other Companion Animals

2) By Indication: Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications

3) By Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies

Global Companion Animal Pharmaceuticals Market Size 2023 to 2028: Graph

Companion Animal Pharmaceuticals Market Size 2024 And Growth Rate

The companion animal pharmaceuticals market size has grown strongly in recent years. It will grow from $15.23 billion in 2023 to $16.63 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to humanization of pets, preventive healthcare measures, rise in pet insurance, changing lifestyle and urbanization, zoonotic disease concerns, zoonotic disease concerns, veterinary healthcare accessibility.

Companion Animal Pharmaceuticals Market Growth Forecast

The companion animal pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $24.2 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to personalized medicine for pets, telehealth and remote veterinary services, focus on nutrition and nutraceuticals, one health initiatives, expansion of veterinary diagnostic services. Major trends in the forecast period include advancements in veterinary medicine, specialized therapeutics for aging pets, regulatory compliance and safety standards, collaborations and partnerships.

Book your 30 minutes free consultation with our research experts

Companion Animal Pharmaceuticals Market Driver: Growing Prevalence Of Zoonotic Diseases Fuels Growth Of Companion Animal Pharmaceuticals Market

The growing prevalence of zoonotic diseases is expected to propel the growth of the companion animal pharmaceuticals market going forward. A zoonotic illness is a disease that can be naturally transferred from vertebrate animals to humans or from people to vertebrate animals. The pharmaceutical industry is embracing modern tactics and strategies that are consistent with one set of health principles in order to combat zoonotic illnesses and lower the likelihood of transmission. For instance, in December 2022, according to a report published by the European Centre for Disease Prevention and Control, a Sweden-based government agency, Campylobacteriosis remains the most prevalent zoonosis, with a notable rise in reported cases to 127,840 in 2022. Chicken and turkey meat accounted for the majority of reported Campylobacteriosis cases. Salmonella, the second most common zoonosis, infected 60,050 individuals. Following Campylobacteriosis and Salmonellosis, Yersiniosis (6,789 cases), Shigatoxin-producing E. coli infections (6,084 cases), and Listeriosis (2,183 cases) were the most frequently reported zoonotic diseases. Therefore, the growing prevalence of zoonotic diseases is driving the growth of the companion animal pharmaceuticals market.

Companion Animal Pharmaceuticals Market Driver: Increased Pet Ownership Is Fueling The Growth Of The Companion Animal Pharmaceutical Market

Increasing pet ownership is expected to boost the growth of the companion animal pharmaceutical market going forward. Pet ownership refers to the relationship between a human and an animal in which the human assumes responsibility for the animal's care and well-being. Growth in the market is fueled by an increasing number of people owning pets and an increased understanding of the value of companion animal disease prevention, diagnosis, and treatment. For instance, in October 2022, according to a report published by the American Veterinary Medical Association, a US-based non-profit organization, there was a 29% increase in the proportion of families with at least one cat in 2022. For households with one dog, the cost of veterinarian services rose to $362 annually in 2022. In 2022, the average yearly cost of veterinary visits for households with cats was $321. Therefore, the increasing pet ownership is driving the growth of the companion animal pharmaceutical market.

Global Companion Animal Pharmaceuticals Market Major Players

Major companies operating in the companion animal pharmaceuticals market report are Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, Eco Animal Health Group plc, Ashish Life Science Pvt. Ltd., Endovac Animal Health, Hipra Laboratories, Indian Immunologicals Ltd., Inovet Group, Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Laboratories Ltd., Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Agrolabo S.p.A., ALS Pvt. Ltd., Zydus Animal Health and Investments Limited, Eli Lilly and Company, IDEXX Laboratories Inc., Merial Limited, Novartis Animal Health Inc., Dechra Pharmaceuticals PLC, Aratana Therapeutics Inc., Phibro Animal Health Corporation, Kindred Biosciences Inc., Jaguar Health Inc., Nexvet Biopharma plc, Sentinel Biomedical Inc., PetMed Express Inc., Neogen Corporation, Heska Corporation, Synbiotics Corporation, Eurovet Animal Health B.V., Vironova AB, Abaxis Inc., Bioiberica S.A.U., Putney Inc., Lohmann Animal Health International

Global Companion Animal Pharmaceuticals Market Trend: Big Data Transforms The Companion Animal Pharmaceutical Market

Embracing big data technologies is a key trend gaining popularity in the companion animal pharmaceuticals. Major companies operating in the companion animal pharmaceuticals market are focused on developing new technological solutions to strengthen their position. For Instance, in April 2022, Elanco Animal Health Incorporated, a US-based company operating in companion animal pharmaceuticals, and Ginkgo Bioworks, a US-based company operating in companion animal pharmaceuticals launched BiomEdit, a microbiome innovation company for creating innovation in animal health. This will provide novel probiotics and other related animal pharmaceuticals for animal health innovation, such as medicated feed ingredients, nutritional health and therapies for livestock and pet animals, and biosecurity technologies for animal illness monitoring.

Global Companion Animal Pharmaceuticals Market Trend: Innovation Product Launches To Meet The Demand

Major companies operating in the companion animal pharmaceutical market are launching innovative products, such as oral flea and tick products, to meet larger customer bases, more sales, and increase revenue. Oral flea and tick products refer to medications that are given by mouth to prevent or treat flea and tick infestations in pets. For instance, in May 2021, Elanco Animal Health Incorporated, a US-based pharmaceutical company, launched Credelio Cat, the first oral flea and tick product for cats. This product's unique feature is that it begins killing fleas on cats in six hours. For cats eight weeks and older, the chewable, small medication keeps its fast-acting, long-lasting anti-flea potency over the entire month. Cats six months and older are also protected against black-legged ticks by Credelio Cat throughout the month.

Companion Animal Pharmaceuticals Market Merger And Acquisition: Dechra Pharmaceuticals Acquired Piedmont Animal Health

In July 2022, Dechra Pharmaceuticals, a UK-based pharmaceutical company, acquired Piedmont Animal Health for $210 million. Through this acquiistion, Dechra will deliver more complementary goods for the European and North American markets and improve its scientific and regulatory skills. Piedmont Animal Health is a US-based companion animal pharmaceutical company.

Regional Outlook For The Global Companion Animal Pharmaceuticals Market

North America was the largest region in the companion animal pharmaceuticals market in 2023. Asia-Pacific is expected to be the fastest-growing region in the companion animal pharmaceuticals market report during the forecast period. The regions covered in the companion animal pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the companion animal pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The companion animal pharmaceuticals market includes revenues earned by entities by providing veterinary pharmaceuticals, vaccines, and health management tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The companion animal pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides companion animal pharmaceuticals market statistics, including companion animal pharmaceuticals industry global market size, regional shares, competitors with a companion animal pharmaceuticals market share, detailed companion animal pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal pharmaceuticals industry. This companion animal pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Companion Animal Pharmaceuticals Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$16.63 billion
Revenue Forecast In 2033	$24.2 billion
Growth Rate	CAGR of 9.8% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Animal Type: Dogs, Cats, Horses, Other Companion Animals 2) By Indication: Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications 3) By Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Elanco Animal Health Incorporated; Boehringer Ingelheim International GmbH; Ceva Santé Animale; Chanelle Pharma; Eco Animal Health Group PLC; Ashish Life Science Pvt. Ltd.; Endovac Animal Health; Hipra Laboratories; Indian Immunologicals Ltd.; Inovet Group; Kyoritsu Seiyaku Corporation; Lutim Pharma Pvt. Ltd.; Merck & Co. Inc.; Norbrook Laboratories Ltd.; Tianjin Ringpu Bio-Technology Co. Ltd.; Vetoquinol S.A.; Virbac S.A.; Zoetis Inc.; Agrolabo S.p.A.; ALS Pvt. Ltd.; Zydus Animal Health and Investments Limited; Eli Lilly and Company; IDEXX Laboratories Inc.; Merial Limited; Novartis Animal Health Inc.; Dechra Pharmaceuticals PLC; Aratana Therapeutics Inc.; Phibro Animal Health Corporation; Kindred Biosciences Inc.; Jaguar Health Inc.; Nexvet Biopharma PLC; Sentinel Biomedical Inc.; PetMed Express Inc.; Neogen Corporation; Heska Corporation; Synbiotics Corporation; Eurovet Animal Health B.V.; Vironova AB; Abaxis Inc.; Bioiberica S.A.U.; Putney Inc.; Lohmann Animal Health International
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Companion Animal Pharmaceuticals Market Characteristics

3. Companion Animal Pharmaceuticals Market Trends And Strategies

4. Companion Animal Pharmaceuticals Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market

4.2. Ukraine-Russia War Impact On the Market

4.3. COVID-19 Impact On the Market

5. Global Companion Animal Pharmaceuticals Market Size and Growth

5.1. Global Companion Animal Pharmaceuticals Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Companion Animal Pharmaceuticals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Companion Animal Pharmaceuticals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Companion Animal Pharmaceuticals Market Segmentation

6.1. Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Dogs

Cats

Horses

Other Companion Animals

6.2. Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Infectious Diseases

Dermatologic Diseases

Pain

Orthopedic Diseases

Behavioral Diseases

Other Indications

6.3. Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Veterinary Hospitals

Veterinary Clinics

Retail Pharmacies

7. Companion Animal Pharmaceuticals Market Regional And Country Analysis

7.1. Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Companion Animal Pharmaceuticals Market

8.1. Asia-Pacific Companion Animal Pharmaceuticals Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Companion Animal Pharmaceuticals Market

9.1. China Companion Animal Pharmaceuticals Market Overview

9.2. China Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Companion Animal Pharmaceuticals Market

10.1. India Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Companion Animal Pharmaceuticals Market

11.1. Japan Companion Animal Pharmaceuticals Market Overview

11.2. Japan Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Companion Animal Pharmaceuticals Market

12.1. Australia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Companion Animal Pharmaceuticals Market

13.1. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Companion Animal Pharmaceuticals Market

14.1. South Korea Companion Animal Pharmaceuticals Market Overview

14.2. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Companion Animal Pharmaceuticals Market

15.1. Western Europe Companion Animal Pharmaceuticals Market Overview

15.2. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Companion Animal Pharmaceuticals Market

16.1. UK Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Companion Animal Pharmaceuticals Market

17.1. Germany Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Companion Animal Pharmaceuticals Market

18.5. France Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Companion Animal Pharmaceuticals Market

19.9. Italy Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Companion Animal Pharmaceuticals Market

20.13. Spain Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Companion Animal Pharmaceuticals Market

21.1. Eastern Europe Companion Animal Pharmaceuticals Market Overview

21.2. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Companion Animal Pharmaceuticals Market

22.1. Russia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Companion Animal Pharmaceuticals Market

23.1. North America Companion Animal Pharmaceuticals Market Overview

23.2. North America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Companion Animal Pharmaceuticals Market

24.1. USA Companion Animal Pharmaceuticals Market Overview

24.2. USA Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Companion Animal Pharmaceuticals Market

25.1. Canada Companion Animal Pharmaceuticals Market Overview

25.2. Canada Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Companion Animal Pharmaceuticals Market

26.1. South America Companion Animal Pharmaceuticals Market Overview

26.2. South America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Companion Animal Pharmaceuticals Market

27.1. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Companion Animal Pharmaceuticals Market

28.1. Middle East Companion Animal Pharmaceuticals Market Overview

28.2. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Companion Animal Pharmaceuticals Market

29.1. Africa Companion Animal Pharmaceuticals Market Overview

29.2. Africa Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Companion Animal Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Companion Animal Pharmaceuticals Market Competitive Landscape

30.2. Companion Animal Pharmaceuticals Market Company Profiles

30.2.1. Elanco Animal Health Incorporated

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Boehringer Ingelheim International GmbH

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Ceva Santé Animale

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Chanelle Pharma

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Eco Animal Health Group plc

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Global Companion Animal Pharmaceuticals Market Competitive Benchmarking

32. Global Companion Animal Pharmaceuticals Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Companion Animal Pharmaceuticals Market

34. Companion Animal Pharmaceuticals Market Future Outlook and Potential Analysis

34.1 Companion Animal Pharmaceuticals Market In 2028 - Countries Offering Most New Opportunities

34.2 Companion Animal Pharmaceuticals Market In 2028 - Segments Offering Most New Opportunities

34.3 Companion Animal Pharmaceuticals Market In 2028 - Growth Strategies

34.3.1 Market Trend Based Strategies

34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations

35.2. Currencies

35.3. Historic And Forecast Inflation Rates

35.4. Research Inquiries

35.5. The Business Research Company

35.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Elanco Animal Health Incorporated Financial Performance

Table 75: Boehringer Ingelheim International GmbH Financial Performance

Table 76: Ceva Santé Animale Financial Performance

Table 77: Chanelle Pharma Financial Performance

Table 78: Eco Animal Health Group plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Elanco Animal Health Incorporated Financial Performance

Figure 75: Boehringer Ingelheim International GmbH Financial Performance

Figure 76: Ceva Santé Animale Financial Performance

Figure 77: Chanelle Pharma Financial Performance

Figure 78: Eco Animal Health Group plc Financial Performance

Global Animal Antibiotics and Antimicrobials Market Outlook, Opportunities And Strategies – Includes Animal Antibiotics and Antimicrobials Market Size

What Is The Veterinary Services Market Overview In 2022?

Global Animal Based Protein Supplements Market 2022 – Market Opportunities And Strategies

Latest Feed Binders Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the cattle feed and feed additives market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the swine feed minerals market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the cattle feed and feed additives market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the poultry healthcare market research report 2022 with industry size, share, segments and market growth

Animal Antibiotics and Antimicrobials Global Market Report 2024 – By Type of Product (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins, Other Antimicrobials and Antibiotics), By Mode of Delivery (Premixes, Oral Powder, Oral Solution, Injection, Other Modes of Delivery), By Animal Type (Food-Producing Animals, Companion Animals) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Animal Based Protein Supplements Global Market Report 2024 – By Product (Protein Powder, Protein Bars, Ready-To-Drink, Other Products), By Raw Materials (Whey, Casein, Egg, Fish, Other Raw Materials), By Application (Pharmaceuticals and Nutraceuticals, Food and Beverages, Infant Formulations, Cosmetics and Personal Care, Animal Feed, And Dietary Supplements), By Distribution Channel (Supermarkets And Hypermarkets, Online Stores, Chemists or Drugstores, Specialty Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Companion Animal Arthritis Global Market Report 2024 – By Type (Dogs, Cats, Other Types), By Indication (Osteoarthritis, Other Arthritis), By Treatment (Medication, Supplements, Other Treatments), By Distribution Channel (Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Companion Animal Veterinary Vaccines Global Market Report 2024 – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Animal Medicine Global Market Report 2024 – By Medicine (Veterinary Pharmaceuticals, Feed Additives), By Type Of Animal (Companion Animal, Livestock Animals), By Type Of Prescription (OTC, Prescription), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Services, Online, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Veterinary Vaccines Global Market Report 2024 – By Application (Livestock Vaccines, Companion Animal Vaccines), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types), By Disease Type (Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Veterinary Antibiotics Global Market Report 2024 – By Product (Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, Others), By End User (Farm Animals, Companion Animals), By Administration (Premixes, Injections, Oral Powders, Oral Solutions, Others) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Veterinary Healthcare Global Market Report 2024 – By Type (Veterinary Services, Veterinary Medical Equipment, Animal Medicine), By Product (Instruments/Equipment, Disposables), By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, Other Animals) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the companion animal pharmaceuticals market?

How will the companion animal pharmaceuticals market drivers and restraints affect the companion animal pharmaceuticals market dynamics? What forces will shape the companion animal pharmaceuticals industry going forward?

The companion animal pharmaceuticals market major growth driver - growing prevalence of zoonotic diseases fuels growth of companion animal pharmaceuticals market. For further insights on the companion animal pharmaceuticals market, request a sample here

What is the forecast market size or the forecast market value of the companion animal pharmaceuticals market ?

The companion animal pharmaceuticals market size has grown strongly in recent years. It will grow from $15.23 billion in 2023 to $16.63 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to humanization of pets, preventive healthcare measures, rise in pet insurance, changing lifestyle and urbanization, zoonotic disease concerns, zoonotic disease concerns, veterinary healthcare accessibility. The companion animal pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $24.2 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to personalized medicine for pets, telehealth and remote veterinary services, focus on nutrition and nutraceuticals, one health initiatives, expansion of veterinary diagnostic services. Major trends in the forecast period include advancements in veterinary medicine, specialized therapeutics for aging pets, regulatory compliance and safety standards, collaborations and partnerships. For further insights on the companion animal pharmaceuticals market, request a sample here

How is the companion animal pharmaceuticals market segmented?

The companion animal pharmaceuticals market is segmentedThe companion animal pharmaceuticals market covered in this report is segmented –
1) By Animal Type: Dogs, Cats, Horses, Other Companion Animals
2) By Indication: Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications
3) By Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies For further insights on the companion animal pharmaceuticals market, request a sample here

Which region has the largest share of the companion animal pharmaceuticals market? What are the other regions covered in the report?

North America was the largest region in the companion animal pharmaceuticals market in 2023. Asia-Pacific is expected to be the fastest-growing region in the companion animal pharmaceuticals market report during the forecast period. The regions covered in the companion animal pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the companion animal pharmaceuticals market, request a sample here.

Who are the major players in the companion animal pharmaceuticals market?

What are the key trends in the companion animal pharmaceuticals market?

Major trend in the companion animal pharmaceuticals market - big data transforms the companion animal pharmaceutical market. For further insights on the companion animal pharmaceuticals market, request a sample here.

What are the major opportunities in the companion animal pharmaceuticals market? What are the strategies for the companion animal pharmaceuticals market?

For detailed insights on the major opportunities and strategies in the companion animal pharmaceuticals market, request a sample here.

How does the companion animal pharmaceuticals market relate to the overall economy and other similar markets?

For detailed insights on companion animal pharmaceuticals market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the companion animal pharmaceuticals industry?

For detailed insights on the mergers and acquisitions in the companion animal pharmaceuticals industry, request a sample here.

What are the key dynamics influencing the companion animal pharmaceuticals market growth? SWOT analysis of the companion animal pharmaceuticals market.

For detailed insights on the key dynamics influencing the companion animal pharmaceuticals market growth and SWOT analysis of the companion animal pharmaceuticals industry, request a sample here.